Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2018 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling, with the three conditions met. Let's analyze the transcript. The call covers various segments. Key points: Willbros acquisition, ACP project delays, pipeline work, utilities, T&D segment. Management discusses many projects and customers. The question asks if a substantial part of forward account consists of reporting on growth/expansion of specific customers/partners etc. that the company already supplies, such that company's volume is a consequence of those parties' trajectories. Look for examples: - ACP project: management discusses delays, but they are waiting for notice to proceed. They have contracts, but it's delayed. They talk about being ready. That's not a counterparty's own expansion trajectory; it's a project delay. - T&D segment: they mention customers awarding work after acquisition, but it's about new awards, not necessarily counterparties' own scaling. They talk about work out there, but not specific counterparties' ramps. - Pipeline: they mention opportunities in Permian, but not specific counterparties' build-outs. - They mention "we are working with some great operations personnel" etc. Management's forward account seems to be about their own actions, project timing, cost reductions, and market opportunities. They don't narrate specific counterparties' own expansion plans as the driver. They mention "abundant opportunities" but not specific counterparties' trajectories. They talk about "we are excited about the opportunity to grow revenue" but not about a specific customer's ramp. The essence: management explains outlook through own actions and broad market conditions, not through narrating counterparties' own scaling. So answer NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.